tiprankstipranks
Trending News
More News >
pc:indiv

Indivi

Indivi is an ISO 13485 and ISO 27001-certified TechBio company headquartered in Basel (Switzerland) and developing future-proof functional biomarkers derived from DHT tools measuring key disability concepts of importance for drug development trials in neuroscience therapeutic areas, e.g. multiple sclerosis, Parkinson's disease and other alpha-synucleinopathies, Alzheimer's disease and related dementias, muscular dystrophies and neuromuscular disorders.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$15M
Total Amount Raised$15M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$15M
Latest Funding Amount$15M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Nov 12, 2025
Investment
$15.00M

Investors

Investor Name
Funding Round
Investment

Related News and Analysis